Nu Skin’s Strategic Moves Highlight Early Signs of Stability Amid Revenue Pressures

Q1 Revenue and Key Metrics Stay Within Guidance Despite Headwinds

Nu Skin Enterprises (NYSE:NUS) delivered first-quarter revenue of $320.6 million, landing within the company’s guidance range and confirming management’s operational discipline in a tough landscape. Adjusted earnings per share for the quarter came in at $0.14 after accounting for one-time charges, down from $0.23 for the prior year period when excluding non-recurring gains.

The quarter continued to reflect contraction across customer, affiliate, and sales leader numbers, but the company’s focus on strategic innovation and market expansion underpinned a cautiously optimistic tone from leadership.

Despite these declines, CEO Ryan Napierski emphasized progress towards strategic priorities, including the upcoming Prysm iO™ intelligent wellness platform roll-out and the formal launch of operations in India later this year.

Margins Show Mixed Trends While Operating Expenses Remain In Focus

Gross margin held steady at 66.9% (or 67.9% when adjusted), with a slight improvement for the core Nu Skin business (76.9% vs. 76.7% last year). Selling and general & administrative expenses remain elevated at a combined 65% of revenue, signaling ongoing investment in transformation and market expansion. Adjusted operating margin reached 3.6%, up from 2.7% last year, indicating better cost control despite top-line pressures.

Segment Data Highlights Geographic Variation

Revenue declines were broad but moderated by relative resilience in some markets. Notably, constant-currency revenue in Mainland China fell by 10%, while Americas and Southeast Asia/Pacific saw steeper contractions. The Rhyz manufacturing segment experienced an 18.7% decrease, although its 'Other' sub-segment grew 28%—hinting at areas of innovation within the business structure.

*Constant-currency change

Renewed Growth Initiatives and Actionable Insights

Management remains focused on empowering its salesforce with the proprietary Prysm iO platform and growing share in emerging markets, specifically targeting a formal entry into India later this year. Importantly, there were ‘early signs of improving paid affiliates and sales leader development’ in several markets, suggesting that Nu Skin’s innovation pipeline is gaining initial traction. Continued investments in anti-aging and health-tracking technology are expected to help stabilize and eventually expand the base of recurring customer subscriptions.

Shareholder Return and Outlook for 2026

Nu Skin returned $8 million to shareholders through dividends and stock repurchases in Q1, maintaining a strong liquidity posture following debt refinancing. For Q2 2026, the company expects revenue between $330 and $360 million and EPS in the $0.15-$0.25 range. Full-year guidance remains unchanged on an adjusted basis, targeting $1.35-$1.50 billion in revenue with EPS of $0.70 to $1.10 (or $0.80 to $1.20 adjusted).

Key Takeaway: Early Stability Indicators Amid Uncertainty and Strategic Transition

While core metrics are under pressure across most regions, management’s faith in its innovation and market expansion strategies shows signs of bearing fruit. Investors should monitor how Prysm iO adoption and Indian market entry impact new customer adds and affiliate engagement through the remainder of the year. The mix of broad-based declines but selective areas of stability suggests Nu Skin’s transformation will take time—and its next phase could hinge on whether these early green shoots convert to bottom-line growth.

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI